The gut microbiota mediates memory impairment under high‐altitude hypoxia via the gut–brain axis in mice
The FEBS Journal · 2025-02 · 292 (4) · 809-826
DOI: 10.1111/febs.17365 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, online erschienen am 23.12.2024. Verfasst von Wenhao Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational and Environmental Health and the Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Env…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Memory Disorders, Hypoxia, Altitude Sickness. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Hypoxia is a predominant risk factor at high altitudes, and evidence suggests that high‐altitude hypoxia alters the gut microbiota, which plays an essential regulatory role in memory function. However, the causal relationship between the gut microbiota and memory impairment under hypoxic conditions remains unclear. In this study, we employed a high‐altitude hypoxia model combined with fecal microbiota transplantation (FMT) approach in mice to explore the effects of the gut microbiota on memory impairment in a hypoxic environment. We observed that high‐altitude hypoxia exposure reduced short‐ and long‐term memory and hippocampus‐dependent fear memory abilities, along with decreased relative abundance of Ligilactobacillus and Muribaculum . Moreover, hypoxic conditions increased intestinal and blood–brain barrier permeability. FMT from hypoxia‐exposed mice into naïve antibiotic‐treated mice resulted in similar memory impairments, Ligilactobacillus and Muribaculum abundance changes, and increased intestinal/blood–brain barrier permeability. Correlation analysis showed a robust positive association between Ligilactobacillus and Muribaculum with hippocampus‐dependent contextual fear memory. Likewise, Ligilactobacillus was positively correlated with short‐term memory. Therefore, Ligilactobacillus and Muribaculum may be key microbes in reducing memory ability in hypoxia, with the intestinal and blood–brain barriers as primary pathways. Our findings provide further evidence for the potential regulatory mechanism by which gut microbiota dysbiosis may contribute to memory impairment in a high‐altitude environment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Occupational and Environmental Health and the Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University,…
- School of Public Health, Shaanxi University of Traditional Chinese Medicine, Xianyang, China.
- State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases & Digestive Diseases of Xijing Hospital, Fourth Military Medical University, Xi'an, China.
- School of Basic Medicine, Fourth Military Medical University, Xi'an, China.
ORCID-Profile: Xuefeng Shen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, W., Wang, Y., Shi, Y., He, F., Zhao, Z., Liu, J., Gao, Z., Zhang, J., & Shen, X. (2025). The gut microbiota mediates memory impairment under high‐altitude hypoxia via the gut–brain axis in mice. The FEBS Journal, 292(4), 809-826. https://doi.org/10.1111/febs.17365
Vancouver
Li W, Wang Y, Shi Y, He F, Zhao Z, Liu J, et al. The gut microbiota mediates memory impairment under high‐altitude hypoxia via the gut–brain axis in mice. The FEBS Journal. 2025;292(4):809-826. doi:10.1111/febs.17365
BibTeX
@article{Li2025,
author = {Li, Wenhao and Wang, Yuhao and Shi, Yi and He, Fenfen and Zhao, Zaihua and Liu, Jingchun and Gao, Zhenbo and Zhang, Jianbin and Shen, Xuefeng},
title = {The gut microbiota mediates memory impairment under high‐altitude hypoxia via the gut–brain axis in mice},
journal = {The FEBS Journal},
year = {2025},
volume = {292},
number = {4},
pages = {809--826},
doi = {10.1111/febs.17365}
}
EUVIMED